Yasuhiro Nakashima
About
Yasuhiro Nakashima is a scholar working on Hematology, Molecular Biology and Immunology.
According to data from OpenAlex, Yasuhiro Nakashima has authored 135 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 30 papers in Molecular Biology and 26 papers in Immunology. Recurrent topics in Yasuhiro Nakashima's work include Hematopoietic Stem Cell Transplantation (30 papers), Immune Cell Function and Interaction (15 papers) and Acute Myeloid Leukemia Research (14 papers). Yasuhiro Nakashima is often cited by papers focused on Hematopoietic Stem Cell Transplantation (30 papers), Immune Cell Function and Interaction (15 papers) and Acute Myeloid Leukemia Research (14 papers). Yasuhiro Nakashima collaborates with scholars based in Japan, United States and China. Yasuhiro Nakashima's co-authors include Makoto Tanaka, Koh Ono, Masayuki Yokode, David Bernard, Jesús Gil, David Beach, Hiroshi Kondoh, Matilde E. Lleonart, Toru Kita and Nagahiro Minato and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.
In The Last Decade
Yasuhiro Nakashima
117 papers receiving 1.7k citations
Peers
Yasuhiro Nakashima
Lisa F. Lincz Australia
Graeme M. Birdsey United Kingdom
Suya Yang United States
Shohei Shimajiri Japan
Laura S. Haneline United States
Charles Lambert Belgium
Yoshie Miura Japan
Hideo Akiyama Japan
Tsuyoshi Fukushima Japan
Peter Burfeind Germany
Citations per year, relative to Yasuhiro Nakashima Yasuhiro Nakashima (= 1×)
peers
Lisa F. Lincz
Countries citing papers authored by Yasuhiro Nakashima
Since
Specialization
Citations
This map shows the geographic impact of Yasuhiro Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Nakashima more than expected).
Fields of papers citing papers by Yasuhiro Nakashima
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Yasuhiro Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Nakashima. The network helps show where Yasuhiro Nakashima may publish in the future.
Co-authorship network of co-authors of Yasuhiro Nakashima
This figure shows the co-authorship network connecting the top 25 collaborators of Yasuhiro Nakashima. A scholar is included among the top collaborators of Yasuhiro Nakashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuhiro Nakashima. Yasuhiro Nakashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Koh, Hideo, Hiroshi Okamura, Mitsutaka Nishimoto, et al.. (2024). Successful treatment with mesenchymal stem cells for steroid-refractory late-onset idiopathic pneumonia syndrome following allogeneic hematopoietic cell transplantation. Transplant Immunology. 86. 102107–102107.
2.
Okamura, Hiroshi, Isao Yokota, Mitsutaka Nishimoto, et al.. (2024). Dynamic Relapse Prediction by Peripheral Blood WT1mRNA after Allogeneic Hematopoietic Cell Transplantation for Myeloid Neoplasms. Transplantation and Cellular Therapy. 30(11). 1088.e1–1088.e12.
3.
Shiomi, Hiroki, Yugo Yamashita, Satoshi Koyama, et al.. (2024). CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. PLoS ONE. 19(3). e0297231–e0297231.
4.
Niki, Makoto, Hiroshi Okamura, Mitsutaka Nishimoto, et al.. (2023). Invasive fungal infection caused by Blastobotrys mokoenaii in an immunocompromised patient with acute myeloid leukemia: A case report. Journal of Infection and Chemotherapy. 30(6). 557–561.
5.
Nakashima, Yasuhiro, et al.. (2023). Posttransplant cyclophosphamide contributes to the impairment of the graft-versus-leukemia effect and the amelioration of graft-versus-host disease with the suppression of alloreactive T cells in a murine stem cell transplant model. Experimental Hematology. 123. 56–65.
6.
Nishimoto, Mitsutaka, Hiroshi Okamura, Yasuhiro Nakashima, et al.. (2023). Recapitulated Late-Onset Inflammatory Toxicities and Progressive Dysautonomia with Persistence of Central Memory CD4+ Chimeric Antigen Receptor T Cells in a Case of Transformed Follicular Lymphoma: Case Report. Acta Haematologica. 146(4). 338–342.
7.
Nakashima, Yasuhiro, Joji Nagasaki, Mitsutaka Nishimoto, et al.. (2022). Immunomodulatory and direct activities of ropeginterferon alfa‐2b on cancer cells in mouse models of leukemia. Cancer Science. 113(7). 2246–2257.
8.
Goto, Hiroaki, Chitose Ogawa, Hiroatsu Iida, et al.. (2022). Safety and Efficacy of Blinatumomab in Japanese Adult and Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Final Results from an Expansion Cohort. Acta Haematologica. 145(6). 592–602.
9.
Nakamae, Hirohisa, Hiroshi Okamura, Asao Hirose, et al.. (2022). A Prospective Study of an HLA-Haploidentical Peripheral Blood Stem Cell Transplantation Regimen Based on Modification of the Dose of Posttransplant Cyclophosphamide for Poor Prognosis or Refractory Hematological Malignancies. Cell Transplantation. 31. 4221169954–4221169954.
10.
Nakashima, Yasuhiro, Naonori Harada, Koichi Yamada, et al.. (2022). Successful treatment of proven coronavirus disease 2019-associated pulmonary aspergillosis with liposomal amphotericin B in a patient with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Journal of Infection and Chemotherapy. 29(2). 223–227.
11.
Hayashi, Tetsuya, Hirohisa Nakamae, Shin’ichi Takeda, et al.. (2021). Increasing numbers of CD19 + CD24highCD38high regulatory B cells and pre-germinal center B cells reflect activated autoimmunity and predict future treatment response in patients with untreated immune thrombocytopenia. International Journal of Hematology. 114(5). 580–590.
12.
Nakamae, Hirohisa, Takahiko Nakane, Hiroshi Okamura, et al.. (2021). A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 115(1). 77–86.
13.
Hayashi, Tetsuya, Yasuhiro Nakashima, Mitsutaka Nishimoto, et al.. (2021). High-Dose Chemotherapy With Autologous Stem Cell Transplantation in a Case of Refractory Peripheral T Cell Lymphoma With Tracheoesophageal Fistula: A Case Report. Transplantation Proceedings. 54(1). 189–192.
14.
Nakamae, Mika, Hirohisa Nakamae, Hideo Koh, et al.. (2021). Predictive value of clinical examination parameters for cardiovascular adverse events during treatment of chronic myeloid leukemia with tyrosine kinase inhibitors. International Journal of Hematology. 115(3). 329–335.
15.
Okamura, Hiroshi, Mika Nakamae, Yasuhiro Nakashima, et al.. (2020). Interactive Web Application for Plotting Personalized Prognosis Prediction Curves in Allogeneic Hematopoietic Cell Transplantation Using Machine Learning. Transplantation. 105(5). 1090–1096.
16.
Kimura, Masahiro, Takahiro Horie, Osamu Baba, et al.. (2020). Homeobox A4 suppresses vascular remodeling by repressing YAP / TEAD transcriptional activity. EMBO Reports. 21(4). e48389–e48389.
17.
Matsumoto, Kana, Mika Nakamae, Hiroshi Okamura, et al.. (2020). Effect of Prophylactic Post-transplant Ponatinib Administration on Outcomes in Patients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 20(12). 813–819.e1.
18.
Nakamae, Hirohisa, Kazuki Fujii, Hiroshi Okamura, et al.. (2019). A prospective observational study of immune reconstitution following transplantation with post‐transplant reduced‐dose cyclophosphamide from HLA ‐haploidentical donors. Transplant International. 32(12). 1322–1332.
19.
Harada, Naonori, Takahiko Nakane, Mika Nakamae, et al.. (2019). Pretransplant serum beta‐2 microglobulin level is a potential novel prognostic marker of overall survival after allogeneic hematopoietic cell transplantation – a retrospective observational study. Transplant International. 33(4). 391–401.
20.
Nakashima, Yasuhiro. (2012). On the Order Degree of Fresh Agricultural Products Supply Chain System——Based on the Data from Japanese Consumer Co-op and the Enlightenments to China. Journal of Business Economics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Lisa F. Lincz Breakdown of academic impact, for papers by Graeme M. Birdsey Breakdown of academic impact, for papers by Suya Yang Breakdown of academic impact, for papers by Shohei Shimajiri Breakdown of academic impact, for papers by Laura S. Haneline Breakdown of academic impact, for papers by Charles Lambert Breakdown of academic impact, for papers by Yoshie Miura Breakdown of academic impact, for papers by Hideo Akiyama Breakdown of academic impact, for papers by Tsuyoshi Fukushima Breakdown of academic impact, for papers by Peter Burfeind